Why the study?
Does coronary artery bypass grafting provide acceptable prognosis and graft durability in patients with concomitant solid tumours?
Does coronary artery bypass grafting provide acceptable prognosis and graft durability in patients with concomitant solid tumours?
Patients with solid organ tumors should not be denied CABG based on concerns over prognosis or graft durability.
Supports offering CABG to patients with solid organ tumours; leaves open need for prospective confirmation.
Based on the results from the present study, CABG should not be denied to patients with solid organ tumours by claiming a worse prognosis or less graft durability. Further studies with larger numbers are warranted.
No takes yet. Share an insight, caveat, or question.
Garatti et al. (2020) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: